Abstract:The Apolipoprotein E (APOE) e4 allele represents a major risk factor for Alzheimer's disease (AD) across all ages between 40 and 90 years, and in both men and women. Memory clinic is a specialized service for people with memory loss and dementia. This prospective study was primarily designed to describe the distribution of APOE genotype among participants with memory complaints in memory clinic, and secondly, to explore the potential risk factors of AD and mild cognitive impairment in memory clinic setting. 385 subjects with memory complaints participated in the study, including 216 patients with AD, 56 individuals with MCI, 17 individuals with SCI, and 96 patients with other types of cognitive impairment. 75 healthy elderly controls were also recruited. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used to derive the APOE genotypes. The frequency of e4 allele was 17.6 percent for the entire sample who had memory complaints. The APOE allele distribution differed between women and men (22.6% vs. 14.9%, P < 0.05). Compared with the control group (7.3%), the prevalence of APOE e4 allele was significantly higher in AD (23.6%) and MCI (21.4%) groups, and slightly increased in SCI (14.7%) group. In education-adjusted models, the odds ratio (OR) = 3.79 for AD (95% CI = 1.82-7.90) and 4.53 for MCI (95% CI = 1.91-10.77). Age was also associated with AD (OR = 5.01, 95% CI = 2.25-11.15) and MCI (OR = 3.04, 95% CI = 1.09-8.51). Female was also associated with AD (OR = 2.77, 95% CI = 1.55-4.96) and MCI (OR = 2.081, 95% CI = 0.97- 4.46). APOE e4 allele and age increased the risk of AD and MCI among patients in memory clinic setting. These individuals need to be monitored closely.

Effects of Apolipoprotein E Allele and Age in Alzheimer’s Disease and Mild Cognitive Impairment in a Memory Clinic Cohort in Beijing